Kymera Therapeutics Inc (NAS:KYMR)
$ 50.94 1.09 (2.19%) Market Cap: 3.30 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 3.69 GF Score: 50/100

Kymera Therapeutics Inc To Host Virtual R&D Day Transcript

Dec 16, 2021 / 01:30PM GMT
Release Date Price: $49.91 (-9.99%)
Bruce N. Jacobs
Kymera Therapeutics, Inc. - CFO

Good morning. I'm Bruce Jacobs, Kymera's Chief Financial Officer. It's my great pleasure to welcome everyone to Kymera's first ever R&D Day, which is being broadcast from our headquarters in Watertown, Massachusetts.

As you may have seen this morning, we issued a press release with highlights of today's meeting. That release is also available on our website. Following the completion of today's session, we'll post both the R&D Day slide deck and the video replay of all presentations to the Events and Presentations section of our website.

Our plan today is to spend the next 2 hours sharing a number of important program and platform updates, as well as new clinical data from the MAD portion of our IRAK 4 Phase I trial. We also hold time at the end of our prepared remarks, likely around 10:30 this morning to take your questions. You'll note there's a question submission bar on your screen that will be opened through the presentations this morning and during the Q&A session. We will collect those questions throughout the morning

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot